Results 231 to 240 of about 69,822 (254)

Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study [PDF]

Chronic Obstructive Pulmonary Diseases (Miami, Fla ), 2017
Background: Co-Suspension™ Delivery Technology offers a novel pharmaceutical platform for inhaled drug therapy. This randomized, double-blind, placebo-controlled, single-dose study (NCT01349868) evaluated the efficacy of a range of doses for formoterol fumarate (FF) delivered using Co-Suspension delivery technology via a pressurized metered dose ...
Sanjay Sethi, Charles Fogarty, Nicola A Hanania   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Author_Response_1 – Supplemental material for Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD

2020
Supplemental material, Author_Response_1 for Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD by Wilfried De Backer, Jan De Backer, Ilse Verlinden, Glenn Leemans, Cedric Van Holsbeke, Benjamin Mignot, Martin Jenkins, Dianne ...
Backer, Wilfried De, Backer, Jan De, Verlinden, Ilse, Leemans, Glenn, Holsbeke, Cedric Van, Mignot, Benjamin, Jenkins, Martin, Griffis, Dianne, Ivanov, Stefan, Fitzpatrick, Jane, Rose, Earl St, Martin, Ubaldo J., Reisner, Colin   +12 more
openaire   +1 more source

Reviewer_1_v.1 – Supplemental material for Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD

2020
Supplemental material, Reviewer_1_v.1 for Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD by Wilfried De Backer, Jan De Backer, Ilse Verlinden, Glenn Leemans, Cedric Van Holsbeke, Benjamin Mignot, Martin Jenkins, Dianne ...
Backer, Wilfried De, Backer, Jan De, Verlinden, Ilse, Leemans, Glenn, Holsbeke, Cedric Van, Mignot, Benjamin, Jenkins, Martin, Griffis, Dianne, Ivanov, Stefan, Fitzpatrick, Jane, Rose, Earl St, Martin, Ubaldo J., Reisner, Colin   +12 more
openaire   +1 more source

Reviewer_2_v.1 – Supplemental material for Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD

2020
Supplemental material, Reviewer_2_v.1 for Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD by Wilfried De Backer, Jan De Backer, Ilse Verlinden, Glenn Leemans, Cedric Van Holsbeke, Benjamin Mignot, Martin Jenkins, Dianne ...
Backer, Wilfried De, Backer, Jan De, Verlinden, Ilse, Leemans, Glenn, Holsbeke, Cedric Van, Mignot, Benjamin, Jenkins, Martin, Griffis, Dianne, Ivanov, Stefan, Fitzpatrick, Jane, Rose, Earl St, Martin, Ubaldo J., Reisner, Colin   +12 more
openaire   +1 more source

Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial

Lancet Respiratory Medicine,the, 2018
Inhaled corticosteroids have been used in patients with chronic obstructive pulmonary disease (COPD), but the potential benefits of their use in triple therapy are not well known. We aimed to compare the efficacy of a triple therapy with corresponding dual therapies in symptomatic patients with moderate to very severe COPD, without a requirement for a ...
Gary T Ferguson, Klaus F Rabe, Fernando J Martinez   +2 more
exaly   +3 more sources

Efficacy and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler (GFF MDI) delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe COPD

Airway pharmacology and treatment, 2018
Objective: To evaluate efficacy and safety of GFF MDI vs placebo MDI and monocomponent MDIs in the Japan subpopulation of the PINNACLE‑4 study (NCT02343458). Methods: In this randomized, double-blind, parallel‑group, 24-week, Phase III study, patients received GFF MDI 14.4/10µg, placebo MDI, glycopyrronium (GP) MDI 14.4µg, or formoterol fumarate ...
Yasuhiro Gon, Koichi Nishi, Kazuhiro Sato, Andrea Maes, Shahid Siddiqui, Nobuya Hayashi, Hajime Hirata, Colin Reisner, Ubaldo J. Martin   +8 more
openaire   +1 more source

Late Breaking Abstract - Impact of eosinophil levels on lung function and exacerbation benefits with co-suspension delivery technology budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) in COPD (KRONOS study subgroup analysis)

Clinical Problems, 2018
Objective: To assess the relationship of baseline eosinophil (EOS) levels with treatment responses to BGF MDI 320/14.4/10 µg (ICS/LAMA/LABA), glycopyrronium/formoterol [GFF] MDI 14.4/10 µg (LAMA/LABA) and budesonide/formoterol [BFF] MDI 320/10 µg (ICS/LABA).
Leonardo Michele Fabbri, Klaus F. Rabe, Fernando J. Martinez, Gary T. Ferguson, Chen Wang, Masakazu Ichinose, Eric Bourne, Shaila Ballal, Patrick Darken, Kiernan Deangelis, Magnus Aurivillius, Paul Dorinsky, Colin Reisner   +12 more
openaire   +1 more source

Functional Respiratory Imaging Assessment of Glycopyrrolate and Formoterol Fumarate Metered Dose Inhalers Formulated Using Co-Suspension Delivery Technology in COPD

B44. COPD: TREATMENT AND OTHER TOPICS, 2019
W. De Backer, J. De Backer, W. Vos, I. Verlinden, C. Van Holsbeke, B. Mignot, M. Jenkins, S. Ivanov, J. Fitzpatrick, E. St. Rose, U.J. Martin, C. Reisner   +11 more
openaire   +1 more source

A Dose Ranging Study of Albuterol Sulfate MDI in Co-Suspension Delivery Technology (AS MDI; PT007) in Patients with Asthma

A32. ASTHMA: CLINICAL STUDIES II, 2019
C. Cappelletti, A. Maes, K. Rossman, E.M. Kerwin, C. Reisner   +4 more
openaire   +1 more source

Stability analysis of the food delivery robot with suspension damping structure

Heliyon, 2022
Shuhai Jiang, Zhongkai Zhou
exaly